Your browser doesn't support javascript.
loading
Treatment of eosinophilic meningitis with a combination of albendazole and corticosteroid.
Southeast Asian J Trop Med Public Health ; 2004 Mar; 35(1): 172-4
Article in English | IMSEAR | ID: sea-33444
ABSTRACT
To study the efficacy of the combination of albendazole and prednisolone for the treatment of eosinophilic meningitis, we conducted a pilot study among Thai patients with eosinophilic meningitis. Patients were given a 2-week course of prednisolone, 60 mg/day and albendazole, 15 mg/kg/ day. The primary observation parameter was the number of patients who still had headache after the 2-week course of treatment. Twenty-six patients were enrolled in the study. There were 3 (11.5%) patients who still had headache after the 2-week course of treatment and the median length of time until complete disappearance of headache was 4 days. Serious side effects were not detected. Treatment for 2 weeks with the combination regimen of albendazole and prednisolone is safe and effective for the treatment of eosinophilic meningitis.
Subject(s)
Full text: Available Index: IMSEAR (South-East Asia) Main subject: Thailand / Severity of Illness Index / Female / Humans / Male / Drug Administration Schedule / Prednisolone / Albendazole / Administration, Oral / Prospective Studies Type of study: Etiology study / Observational study / Prognostic study / Risk factors Country/Region as subject: Asia Language: English Journal: Southeast Asian J Trop Med Public Health Year: 2004 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: IMSEAR (South-East Asia) Main subject: Thailand / Severity of Illness Index / Female / Humans / Male / Drug Administration Schedule / Prednisolone / Albendazole / Administration, Oral / Prospective Studies Type of study: Etiology study / Observational study / Prognostic study / Risk factors Country/Region as subject: Asia Language: English Journal: Southeast Asian J Trop Med Public Health Year: 2004 Type: Article